Atea Pharmaceuticals (AVIR) Q3 2024 Earnings

Aug 7Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.75
-0.63
-0.52
-0.4

Details

Expected EPS
-0.662932
Actual EPS
-0.48
Surprise EPS
0.18
Surprise Percent
+27.59%

Description

⁨Atea Pharmaceuticals⁩ (⁦AVIR⁩) has reported earnings of ⁦-0.48⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts